Myocarditis

Myocarditis is an inflammatory disease of the heart muscle, or myocardium, that can significantly impair cardiac function and lead to serious complications including heart failure, arrhythmias, and sudden death. This condition occurs when the muscular walls of the heart become inflamed due to infectious agents, immune-mediated processes, or toxic exposures. While the true prevalence of myocarditis in cats is uncertain because many cases are subclinical or undiagnosed, it is recognized as an important cause of cardiac disease, particularly in young cats and those with concurrent viral infections. Myocarditis can affect cats of any age, breed, or sex, though certain infections causing myocarditis may be more common in specific populations.

The causes of feline myocarditis are diverse, with viral infections being among the most commonly identified triggers. Feline panleukopenia virus, feline leukemia virus, feline immunodeficiency virus, and coronaviruses have all been associated with myocardial inflammation. Protozoal organisms, particularly Toxoplasma gondii, can cause myocarditis as part of systemic toxoplasmosis. Bacterial infections, while less common, may extend to the myocardium or cause secondary inflammatory damage. In many cases, the specific cause is never definitively identified, and the condition may be classified as idiopathic myocarditis, which may represent immune-mediated disease or undetected infection. The inflammatory process damages heart muscle cells, impairs contractility, and can trigger dangerous arrhythmias.

The impact of myocarditis on cardiac function varies from minimal effects in mild cases to severe heart failure in more serious inflammation. When the heart muscle is inflamed, it cannot contract normally, leading to reduced cardiac output and potential signs of heart failure. The inflammatory process can also disrupt the electrical conduction system of the heart, causing arrhythmias that may range from benign extra beats to life-threatening ventricular tachycardia or fibrillation. In severe cases, massive myocardial damage can lead to rapid deterioration and death. Even cats who survive acute myocarditis may develop chronic cardiomyopathy from residual myocardial scarring and damage.

Treatment and prognosis for myocarditis depend heavily on the underlying cause, severity of cardiac involvement, and timeliness of intervention. When a specific infectious cause is identified, targeted antimicrobial therapy may be effective. Supportive care including management of arrhythmias and heart failure is essential regardless of cause. Immunosuppressive therapy may be considered in immune-mediated cases, though this must be balanced against the risk of worsening infection. Early recognition and treatment improve outcomes, but diagnosis can be challenging because symptoms are often nonspecific and overlap with other conditions. Cats with mild myocarditis may recover completely, while those with severe disease face guarded prognosis. Long-term cardiac monitoring is important for survivors to detect any residual damage or progressive cardiomyopathy.

The primary causes of myocarditis in cats include viral infections, protozoal organisms, bacterial infections, and immune-mediated processes. Viral myocarditis is perhaps the most important category, with feline panleukopenia virus being a well-documented cause, particularly in neonatal kittens who may develop myocarditis as part of feline panleukopenia syndrome. Feline leukemia virus and feline immunodeficiency virus can cause myocardial inflammation either directly or through immunosuppression that predisposes to secondary infections. Coronaviruses, including those associated with feline infectious peritonitis, may involve the heart as part of systemic disease. Other viruses suspected or documented to cause feline myocarditis include calicivirus and paramyxoviruses.

Protozoal and parasitic causes of myocarditis merit special attention due to their clinical importance. Toxoplasma gondii is the most significant protozoal cause, with myocarditis occurring as part of systemic or localized toxoplasmosis, particularly in immunocompromised cats. The organism invades cardiac muscle cells, causing inflammation and tissue destruction. Neospora caninum and Sarcocystis species can similarly affect the myocardium. While less common in cats than dogs, Trypanosoma cruzi, which causes Chagas disease, can cause myocarditis in endemic regions. Heartworm disease, caused by Dirofilaria immitis, can lead to cardiac inflammation through direct effects and immune responses to the parasites.

Genetic and hereditary factors do not directly cause myocarditis but may influence susceptibility to infections or immune responses that lead to cardiac inflammation. Cats with immunodeficiency from genetic causes or acquired conditions are more vulnerable to infections capable of causing myocarditis. Certain breeds might theoretically have variations in immune function affecting their response to infectious agents, though specific associations have not been documented. The genetic makeup of the causative organism also matters, as different strains of viruses or other pathogens may have varying propensity to affect the heart.

Environmental and lifestyle factors influence exposure to myocarditis-causing agents. Outdoor cats have greater exposure to Toxoplasma gondii through hunting and consuming infected prey. Cats in multicat environments, shelters, or catteries face higher risk of viral infections including panleukopenia and respiratory viruses. Stress from crowding, poor nutrition, or concurrent disease can impair immune function and increase susceptibility. Kittens from unvaccinated mothers lack protective maternal antibodies and are particularly vulnerable to viral myocarditis. Geographic location affects exposure to certain parasitic causes.

The mechanism of myocardial damage in myocarditis involves both direct pathogen effects and immune-mediated injury. When infectious organisms invade heart muscle cells, they replicate and cause direct cellular damage and death. The immune response to infection, while necessary to control the pathogen, also contributes to tissue damage through inflammation, cytokine release, and immune cell activity. In some cases, molecular mimicry, where pathogen proteins resemble host cardiac proteins, may trigger autoimmune attack on heart tissue that persists even after the infection is cleared. This immune-mediated component explains why cardiac damage may progress despite successful treatment of the underlying infection and why immunosuppressive therapy may sometimes be beneficial.

Early warning signs of myocarditis in cats are frequently subtle and easily overlooked, as the heart has significant reserve capacity and cats are adept at hiding illness. Mild lethargy or decreased activity may be the first change, but is often attributed to minor illness or normal variation. Reduced appetite without apparent cause could indicate developing cardiac dysfunction or systemic illness. Subtle changes in breathing pattern, such as slightly increased respiratory rate during rest, might be present but are difficult for most owners to detect. Some cats may be less interested in play or exhibit decreased grooming. Because these early signs are nonspecific, myocarditis is often not suspected until more obvious symptoms develop or acute decompensation occurs.

Common symptoms of myocarditis relate to decreased cardiac function, arrhythmias, or effects of the underlying cause. Cats may develop exercise intolerance, becoming winded or tired with minimal activity. Increased respiratory rate or effort indicates fluid accumulation in or around the lungs from heart failure. Weakness or episodic collapse may occur due to arrhythmias or poor cardiac output. Fever is often present if infection is the underlying cause. Appetite loss and weight loss are common with systemic illness. Pale or gray gums suggest reduced cardiac output or anemia from concurrent disease. Some cats present with signs related to the primary infection, such as neurological symptoms with toxoplasmosis or gastrointestinal signs with panleukopenia.

Behavioral changes in cats with myocarditis reflect general malaise and cardiac compromise. Affected cats typically become withdrawn and inactive, seeking isolated resting spots. They may be reluctant to interact with family members or other pets. Sleep patterns often change, with cats sleeping more than usual or in unusual locations. Appetite changes from complete anorexia to pickiness are common. Some cats may vocalize more, possibly indicating discomfort or difficulty breathing. Hiding behavior is frequently observed. Changes in elimination habits may occur if the cat is too weak to reach the litter box or has concurrent organ effects.

Physical signs detectable on veterinary examination may include rapid heart rate, though bradycardia can occur with certain conduction disturbances. Irregular heart rhythm is common due to arrhythmias. Heart murmurs may be present from impaired valve function or altered blood flow. Abnormal lung sounds or muffled heart sounds indicate fluid accumulation. Weak pulse quality suggests reduced cardiac output. Fever is frequently detected with infectious causes. Dehydration may be present from reduced fluid intake or concurrent gastrointestinal losses. Enlarged liver or spleen might be palpable with systemic infection. Signs specific to the underlying cause, such as chorioretinal lesions with toxoplasmosis, may be present.

Symptom progression in myocarditis can be unpredictable, ranging from gradual worsening over days to weeks to sudden, catastrophic decline. Cats with mild inflammation may remain stable or even improve as the underlying cause resolves. Those with more severe involvement typically show progressive exercise intolerance, increasing respiratory effort, and declining appetite. Arrhythmias may become more frequent or severe over time. Some cats experience acute decompensation with sudden onset of severe respiratory distress, collapse, or death, sometimes without prior obvious symptoms. This unpredictable course emphasizes the importance of close monitoring for cats with suspected myocarditis.

Emergency symptoms requiring immediate veterinary attention include severe difficulty breathing, open-mouth breathing, or respiratory distress of any kind. Sudden collapse, loss of consciousness, or inability to stand indicates critical cardiac compromise. Persistent rapid, weak, or irregular pulse suggests serious arrhythmia or poor cardiac output. Blue or gray gums indicate oxygen deprivation. Seizures or other neurological emergencies may occur with severe cardiac dysfunction or concurrent brain involvement. Any cat with known or suspected myocarditis who shows sudden worsening of symptoms needs emergency evaluation. Complete refusal to eat or drink for more than twenty-four hours in an ill cat warrants urgent attention.

The initial veterinary examination for suspected myocarditis includes comprehensive assessment focusing on cardiac and systemic findings. The veterinarian will obtain a detailed history including vaccination status, exposure to other cats, outdoor access, recent illness, and any observed symptoms. Physical examination emphasizes cardiovascular assessment with careful auscultation for abnormal heart rhythms, murmurs, or gallop rhythms. Respiratory assessment checks for increased rate or effort and abnormal lung sounds. Fever is assessed by rectal temperature. The examination looks for signs of underlying infectious disease, including ocular abnormalities, neurological deficits, lymph node enlargement, and abdominal organ changes.

Diagnostic testing for myocarditis aims to identify cardiac involvement and underlying causes. Blood work including complete blood count and serum chemistry evaluates overall health and may show signs of infection, inflammation, or organ effects. Cardiac biomarkers including cardiac troponin I, which rises with heart muscle damage, provide evidence of myocardial injury and are particularly useful for detecting myocarditis. Infectious disease testing should include feline leukemia virus and feline immunodeficiency virus testing for all cats, along with toxoplasmosis serology, panleukopenia PCR, and other tests based on clinical suspicion. Blood cultures may be indicated if bacterial infection is suspected. Chest radiographs assess heart size and lung changes.

Echocardiography is valuable for evaluating cardiac structure and function in cats with suspected myocarditis. Findings may include decreased contractility of the heart muscle, ventricular dilation, or wall motion abnormalities. Pericardial effusion is sometimes present. However, echocardiographic findings in myocarditis can be subtle or absent, particularly in early or mild cases, and normal echocardiography does not rule out the condition. Electrocardiography records the heart's electrical activity and is essential for identifying arrhythmias, which are common in myocarditis. Various rhythm disturbances may be detected, including ventricular premature complexes, ventricular tachycardia, supraventricular arrhythmias, and conduction blocks.

Confirming the diagnosis of myocarditis definitively requires cardiac biopsy with histopathological examination showing inflammatory cell infiltration of the myocardium, but this invasive procedure is rarely performed in clinical practice due to risks and technical challenges. The diagnosis is typically presumptive, based on compatible clinical signs, evidence of cardiac dysfunction or arrhythmias, elevated cardiac troponin levels, identification of an underlying cause known to affect the heart, and exclusion of other cardiac diseases. Response to treatment of the underlying cause, with improvement in cardiac parameters, supports the diagnosis retrospectively. Advanced imaging such as cardiac MRI, while used in human medicine to detect myocardial inflammation, is not readily available for feline patients.

Emergency treatment for cats presenting with severe myocarditis and cardiac decompensation focuses on stabilization and life support. Cats in congestive heart failure require supplemental oxygen and careful fluid management to avoid worsening pulmonary edema. Diuretics such as furosemide reduce fluid accumulation. Antiarrhythmic medications address life-threatening rhythm disturbances, with specific drug selection based on the type of arrhythmia. Lidocaine may be used for ventricular arrhythmias, while other agents address different rhythm abnormalities. Pain management and sedation reduce stress and oxygen demand. Temperature support may be needed for cats with severe systemic illness. Once stabilized, attention turns to identifying and treating the underlying cause.

Medical management of the underlying cause is essential when an infectious etiology is identified. For toxoplasmosis-associated myocarditis, clindamycin is the treatment of choice, often administered for several weeks. Trimethoprim-sulfonamide is an alternative. For bacterial myocarditis, appropriate antibiotics based on culture and sensitivity results are used. There are no specific antiviral treatments for most feline viral infections, so management is supportive while the immune system clears the infection. For cats with feline leukemia or immunodeficiency virus, managing secondary infections and providing supportive care are priorities. Immunosuppressive therapy with corticosteroids may be considered for suspected immune-mediated myocarditis but must be used cautiously if infection is present.

Supportive cardiac care addresses the consequences of myocardial damage regardless of the underlying cause. ACE inhibitors such as enalapril or benazepril help manage heart failure and may provide some cardioprotective effects. Beta-blockers may be used cautiously to control heart rate, though they can worsen heart failure and must be initiated carefully. Positive inotropes like pimobendan may support contractility in cats with significantly reduced cardiac function. Diuretics control fluid accumulation. Antiarrhythmic medications are continued as needed to maintain stable heart rhythm. Nutritional support ensures adequate caloric intake, which may require appetite stimulants or feeding tubes in severely ill cats.

Surgical intervention plays essentially no role in the management of myocarditis, as this is primarily a medical condition. Rarely, pericardiocentesis might be needed if significant pericardial effusion is causing cardiac tamponade. Pacemaker implantation could theoretically be considered for cats with persistent severe bradyarrhythmias or complete heart block, though this is uncommon. The focus of treatment remains on medical therapy directed at the underlying cause and supportive cardiac care.

Alternative and complementary treatments have limited established roles in feline myocarditis but may provide supportive benefits. Antioxidant supplements including vitamin E, vitamin C, and coenzyme Q10 might help reduce oxidative stress associated with inflammation. Omega-3 fatty acids have anti-inflammatory properties that could theoretically benefit myocardial inflammation. L-carnitine and taurine supplementation supports cardiac metabolism. Stress reduction through environmental management supports healing. These approaches should complement rather than replace conventional treatment and should be discussed with the veterinarian to avoid interactions with prescribed medications.

Treatment decisions in myocarditis consider the severity of cardiac involvement, identified or suspected underlying cause, and overall patient status. Mild cases may require only treatment of the underlying cause with monitoring for cardiac complications. Severe cases demand intensive cardiac support alongside cause-directed therapy. Cost considerations include diagnostic testing, hospitalization if needed, and ongoing medication. Prognosis discussions should be honest about the uncertainty inherent in this condition, as outcomes range from complete recovery to death despite treatment. Quality of life assessment helps guide decisions about treatment intensity, and owners should be prepared for the possibility that some cats will not survive despite appropriate care.

The recovery timeline for myocarditis varies substantially based on underlying cause, severity of cardiac involvement, and response to treatment. Cats with mild, infection-associated myocarditis may improve within days to weeks as the infection resolves, though cardiac monitoring should continue for several months to ensure complete recovery. Those with severe cardiac dysfunction may require weeks to months of intensive management before stabilization, if recovery is achieved at all. Arrhythmias may persist even after the underlying cause is resolved, requiring ongoing antiarrhythmic therapy. Complete resolution of cardiac abnormalities is possible in some cases but may take months, and some cats retain permanent cardiac damage.

Post-treatment care involves gradual reduction of cardiac medications as tolerated, continued monitoring for recurrence, and activity management. Serial echocardiography evaluates improvement or persistence of structural and functional abnormalities. Electrocardiography or Holter monitoring assesses arrhythmia control. Blood work monitors for medication effects and underlying disease status. Cardiac biomarkers may be rechecked to confirm resolution of active myocardial damage. Activity restriction is appropriate during recovery, with gradual return to normal activity as cardiac function improves. Recheck examinations are typically more frequent initially, with intervals extending as stability is demonstrated.

Prognosis for cats with myocarditis depends on multiple factors. The underlying cause matters significantly, with viral myocarditis in young kittens carrying particularly poor prognosis while toxoplasmosis-associated disease may respond well to treatment. Severity of cardiac involvement at presentation influences outcome, with cats in heart failure or with severe arrhythmias having guarded prognosis. Response to initial therapy provides prognostic information, as cats who improve in the first few days of treatment generally fare better than those who do not respond. Cats who survive the acute phase may have good long-term quality of life, though some develop chronic cardiomyopathy from residual myocardial damage.

The long-term outlook for myocarditis survivors includes the possibility of complete recovery, stable compensated cardiac disease, or progressive cardiomyopathy. Some cats recover fully with no detectable residual cardiac abnormalities. Others develop dilated cardiomyopathy or other chronic cardiac conditions from myocardial scarring and remodeling, requiring lifelong management. Periodic cardiac reassessment, typically every six to twelve months, monitors for any progression. Any return of symptoms should prompt immediate evaluation. Preventing reinfection with the causative organism, when relevant, may reduce risk of recurrence or additional cardiac damage. Vaccination and parasite prevention protect against some causes of myocarditis.

Primary prevention of myocarditis focuses on protecting cats from the infections that most commonly cause cardiac inflammation. Vaccination against feline panleukopenia virus is highly effective and should be part of every cat's core vaccination protocol, protecting against one of the most important causes of viral myocarditis. Vaccination against other respiratory viruses, while not directly preventing myocarditis, reduces overall infectious disease burden. Testing and isolating cats positive for feline leukemia virus or feline immunodeficiency virus prevents transmission to other cats. Preventing exposure to Toxoplasma gondii through keeping cats indoors and not feeding raw meat reduces risk of toxoplasmosis-associated myocarditis.

Environmental prevention strategies minimize exposure to infectious agents and support immune function. Indoor housing dramatically reduces exposure to many infectious causes of myocarditis, including Toxoplasma from hunting and viral diseases from infected cats. For cats with outdoor access, keeping them in at night when hunting is most active may reduce prey consumption. Avoiding feeding raw or undercooked meat eliminates this route of Toxoplasma exposure. Maintaining clean, uncrowded living conditions reduces stress and infectious disease transmission. Proper quarantine of new cats before introducing them to established households prevents disease introduction.

Dietary approaches to preventing myocarditis relate primarily to supporting overall immune function and cardiac health. Feeding complete and balanced commercial diets ensures adequate nutrition, including taurine, which is essential for cardiac function. Not feeding raw meat eliminates dietary Toxoplasma exposure. Maintaining appropriate body weight through proper feeding supports overall health. Adequate hydration promotes normal organ function. There are no specific supplements proven to prevent myocarditis, but overall nutritional adequacy supports the body's ability to resist and respond to infection.

Health maintenance through regular veterinary care supports prevention and early detection of conditions that could lead to myocarditis. Routine wellness examinations assess overall health and provide opportunities for vaccination updates. Testing for feline leukemia virus and feline immunodeficiency virus identifies infected cats for appropriate management. Prompt treatment of any infections reduces risk of systemic spread and cardiac involvement. Regular parasite prevention, particularly in endemic areas for heartworm or other relevant parasites, protects against parasitic causes of myocarditis.

Early intervention when infections are diagnosed may prevent progression to cardiac involvement. Prompt, appropriate treatment of toxoplasmosis before cardiac damage occurs provides the best outcome. Supportive care for cats with viral infections helps the immune system control infection before extensive organ damage develops. Monitoring cats recovering from any severe systemic infection for cardiac abnormalities allows early detection if myocarditis develops. For cats with known immunosuppression from feline leukemia or immunodeficiency virus, enhanced monitoring and prompt treatment of any illness may prevent secondary infections from causing myocardial damage.

Daily management of a cat recovering from or living with residual effects of myocarditis centers on medication administration, monitoring, and supportive care. Cats on cardiac medications require consistent dosing schedules, and owners should understand the purpose of each medication. Keeping a medication log helps ensure compliance and track any missed doses. Daily observation of breathing pattern, activity level, and appetite provides early warning of any changes in condition. Counting resting respiratory rate regularly gives objective data about cardiac status, with rates consistently above thirty breaths per minute warranting veterinary contact. Noting any coughing, weakness, or episodes of collapse is important for reporting to the veterinarian.

Home environment modifications support cats with cardiac compromise from myocarditis. Providing easily accessible resources including food, water, and litter boxes reduces physical demands. Eliminating the need to climb stairs by placing essentials on each floor helps cats with reduced exercise tolerance. Quiet resting areas allow for undisturbed sleep, which is important for healing. Temperature regulation avoids extremes that could stress the cardiovascular system. Stress reduction through stable routines and minimizing household changes supports recovery. For multi-cat households, ensuring the recovering cat has access to resources without competition reduces social stress.

Maintaining quality of life for cats after myocarditis involves balancing necessary restrictions with opportunities for contentment. While strenuous activity should be avoided, gentle interaction and mental stimulation remain important. Comfortable resting spots in favorite locations provide security and comfort. Continued social bonding with family members through gentle petting and calm interaction maintains the human-animal connection. Appropriate environmental enrichment, such as window perches for watching outdoor activity, provides interest without physical exertion. Grooming assistance helps cats who are too tired or unwell to maintain their coats properly.

Ongoing veterinary monitoring is essential for cats who have experienced myocarditis. Regular recheck examinations assess cardiac status and response to treatment. Echocardiography monitors structural and functional changes over time. Electrocardiography or Holter monitoring evaluates arrhythmia control. Blood work assesses medication effects and underlying disease status. The monitoring interval depends on disease severity and stability, ranging from monthly for unstable patients to every six months for those doing well. Any change in symptoms should prompt earlier evaluation. Vaccination and parasite prevention should continue as appropriate for the individual cat's risk factors.

Caregiver support helps owners manage the challenges of caring for a cat with cardiac disease. Understanding the condition, treatment goals, and what to expect helps owners feel more confident in their care. Learning to recognize warning signs and when to seek emergency care reduces anxiety. Connecting with support resources, including online communities of owners with cardiac disease cats, provides emotional support and practical tips. Financial planning for ongoing medication costs and veterinary visits reduces stress. Open communication with the veterinary team about the cat's quality of life helps guide decisions as the disease progresses, including end-of-life planning when appropriate.

Myocarditis does not show specific breed predilections in cats, as it is primarily caused by infectious agents that can affect any cat regardless of breed. However, factors related to lifestyle and exposure may indirectly influence risk in ways that correlate with breed-associated living situations. Purebred cats kept exclusively indoors and obtained from reputable breeders may have lower exposure to some infectious causes, while cats from shelter environments, regardless of breed, face higher infectious disease pressure. Breeds with known immunological variations might theoretically respond differently to infections, but specific associations with myocarditis susceptibility have not been documented.

Age and immune status appear more important than breed in determining myocarditis risk. Neonatal kittens exposed to panleukopenia virus are particularly vulnerable to viral myocarditis, regardless of breed. Cats with immunosuppression from feline leukemia virus, feline immunodeficiency virus, or other causes have reduced ability to control infections before cardiac involvement develops. Young, unvaccinated cats of any breed are at risk for viral causes of myocarditis. Older cats with declining immune function may be more susceptible to certain infections. Cats receiving immunosuppressive medications are at increased risk for opportunistic infections that could affect the heart.

Screening recommendations for myocarditis relate to identifying predisposing factors and underlying infections rather than breed-based screening. All cats should receive core vaccinations including panleukopenia vaccine. Testing for feline leukemia virus and feline immunodeficiency virus identifies cats with immunosuppression requiring enhanced monitoring. Cats with unexplained fever, arrhythmias, or cardiac dysfunction should be tested for common infectious causes including toxoplasmosis. Cardiac screening with echocardiography and cardiac biomarkers is appropriate for cats with suspected myocarditis or those recovering from severe systemic infections. Breeders should maintain good hygiene and vaccination protocols to minimize infectious disease in catteries.

Myocarditis frequently co-occurs with systemic manifestations of the underlying infectious cause, creating complex clinical presentations. Toxoplasmosis-associated myocarditis is often accompanied by fever, muscle pain, neurological signs, ocular inflammation, and hepatic or pulmonary involvement. Panleukopenia causes severe gastrointestinal disease, immunosuppression, and sometimes cerebellar hypoplasia in kittens. Feline infectious peritonitis causes widespread organ inflammation along with any cardiac effects. These concurrent conditions affect treatment priorities and overall prognosis. Managing myocarditis in the context of multi-organ disease requires addressing the most life-threatening issues while providing comprehensive supportive care.

Conditions that may present similarly to myocarditis include other forms of cardiomyopathy, particularly dilated cardiomyopathy, which can look identical on echocardiography and may actually represent end-stage myocarditis in some cases. Hypertrophic cardiomyopathy causes different structural changes but may present with similar arrhythmias. Pericarditis, inflammation of the sac surrounding the heart, can occur alongside myocarditis or independently and causes similar symptoms. Cardiac neoplasia can cause arrhythmias and cardiac dysfunction. Non-cardiac causes of the presenting symptoms, including respiratory disease, anemia, and other systemic illnesses, must be considered in the differential diagnosis. Accurate diagnosis requires comprehensive evaluation.

Potential complications of myocarditis include progression to dilated cardiomyopathy if significant myocardial damage and scarring occur. Arrhythmias may persist after resolution of active inflammation, requiring long-term antiarrhythmic therapy. Congestive heart failure can develop during acute illness or later from chronic cardiac remodeling. Thromboembolism is possible if cardiac dysfunction leads to blood stasis and clot formation. Sudden death from malignant arrhythmias remains a risk during and after active myocarditis. These complications emphasize the importance of long-term monitoring even after apparent recovery from the acute episode.